Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Alba (ABA)

Abaco Capital
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:ABA
DateTimeSourceHeadlineSymbolCompany
09/05/201807:01UK RegulatoryAIM Cancellation - Abaco Capital plcLSE:ABAAbaco Capital
08/05/201814:22Alliance NewsAlliance NewsAbaco Capital Secures Investor Approval For Delisting And Liquidation (ALLISS)LSE:ABAAbaco Capital
08/05/201812:13UK RegulatoryAbaco Capital PLC Result of AGM and Notice of CancellationLSE:ABAAbaco Capital
08/05/201807:44Alliance NewsAlliance News*Abaco Capital Shares Temporarily Suspended From AIM Trading (ALLISS)LSE:ABAAbaco Capital
08/05/201807:30UK RegulatoryAIM Suspension - Abaco Capital plcLSE:ABAAbaco Capital
04/05/201811:09Alliance NewsAlliance NewsAbaco Capital Share Trading To Be Suspended Ahead Of Delisting VoteLSE:ABAAbaco Capital
04/05/201807:00UK RegulatoryAbaco Capital PLC Suspension of trading on AIMLSE:ABAAbaco Capital
06/04/201808:56Alliance NewsAlliance NewsAbaco Capital Proposes AIM Delisting, Fails To Find Takeover Target (ALLISS)LSE:ABAAbaco Capital
06/04/201807:00UK RegulatoryAbaco Capital PLC Proposed Cancellation of AdmissionLSE:ABAAbaco Capital
06/04/201807:00UK RegulatoryAbaco Capital PLC Final ResultsLSE:ABAAbaco Capital
27/02/201807:02UK RegulatoryAbaco Capital PLC Strategy updateLSE:ABAAbaco Capital
21/12/201710:00UK RegulatoryOxford Pharmascience Group PLC Completion of DemergerLSE:ABAAbaco Capital
19/12/201715:50UK RegulatoryOxford Pharmascience Group PLC Confirmation of Capital ReductionsLSE:ABAAbaco Capital
04/12/201714:14UK RegulatoryOxford Pharmascience Group PLC Subdivision of CapitalLSE:ABAAbaco Capital
29/11/201711:09Alliance NewsAlliance NewsOxford Pharmascience Gets US Regulatory Boost For OXPZero ProductLSE:ABAAbaco Capital
29/11/201707:00UK RegulatoryOxford Pharmascience Group PLC FDA Advice on OXPzero Ibuprofen OTC OpportunityLSE:ABAAbaco Capital
27/11/201711:55UK RegulatoryOxford Pharmascience Group PLC Result of General MeetingLSE:ABAAbaco Capital
22/11/201715:03Alliance NewsAlliance NewsOxford Pharmascience Says Richard Griffiths Has Raised Holding To 23% (ALLISS)LSE:ABAAbaco Capital
22/11/201714:48UK RegulatoryOxford Pharmascience Group PLC Holding(s) in CompanyLSE:ABAAbaco Capital
22/11/201709:39UK RegulatoryOxford Pharmascience Group PLC Holding(s) in CompanyLSE:ABAAbaco Capital
20/11/201716:40UK RegulatoryOxford Pharmascience Group PLC Second Price Monitoring ExtnLSE:ABAAbaco Capital
20/11/201716:35UK RegulatoryOxford Pharmascience Group PLC Price Monitoring ExtensionLSE:ABAAbaco Capital
20/11/201711:48Alliance NewsAlliance NewsOxford Pharmascience Group Gets Regulatory Boost For OXPZero In SwedenLSE:ABAAbaco Capital
20/11/201707:00UK RegulatoryOxford Pharmascience Group PLC MPA Advice on OXPzeroT Ibuprofen OTC OpportunityLSE:ABAAbaco Capital
10/11/201708:53Alliance NewsAlliance NewsOxford Pharmascience Shares Jump As It Announces Demerger (ALLISS)LSE:ABAAbaco Capital
10/11/201707:00UK RegulatoryOxford Pharmascience Group PLC Announcement of demergerLSE:ABAAbaco Capital
02/10/201712:14Alliance NewsAlliance NewsOxford Pharmascience Suspends OXPzero Development As It Mulls AdviceLSE:ABAAbaco Capital
02/10/201710:15UK RegulatoryOxford Pharmascience Group PLC MHRA Advice on OXPzeroT Ibuprofen OTC OpportunityLSE:ABAAbaco Capital
25/09/201711:46Alliance NewsAlliance NewsOxford Pharmascience Loss Widens As Regulatory Hurdles Slow ProgressLSE:ABAAbaco Capital
25/09/201707:00UK RegulatoryOxford Pharmascience Group PLC Interim ResultsLSE:ABAAbaco Capital
 Showing the most relevant articles for your search:LSE:ABA